MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.
China-headquartered medical device maker MicroPort Scientific Corporation has invested $47m to co-lead a $150m series C round for France-based pacemaker and defibrillator spinoff MicroPort Cardiac Rhythm Management (CRM). Hedge fund manager Hillhouse Capital Group co-led the round with $26m, and the rest came from property developer Country Garden’s investment arm, Country Garden Venture Capital, as…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.